ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Clinical trials for ACUTE ON CHRONIC LIVER FAILURE (ACLF) explained in plain language.
Never miss a new study
Get alerted when new ACUTE ON CHRONIC LIVER FAILURE (ACLF) trials appear
Sign up with your email to follow new studies for ACUTE ON CHRONIC LIVER FAILURE (ACLF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exosome injection shows promise for liver failure in small trial
Disease control OngoingThis study tests whether adding PT-MSCs exosome injections to standard care can help people with acute-on-chronic liver failure live longer. Twenty adults aged 18–65 will receive either standard treatment alone or standard treatment plus four exosome infusions over 10 days. The m…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: EARLY_PHASE1 • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 17, 2026 11:37 UTC
-
Cell injection aims to prevent deadly liver complication
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests whether injecting special liver-like cells into the belly muscle can help prevent or treat Small-for-Size Syndrome, a serious complication after liver surgery. The trial will enroll 12 patients with liver failure to check safety and early signs of ben…
Matched conditions: ACUTE ON CHRONIC LIVER FAILURE (ACLF)
Phase: EARLY_PHASE1 • Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated May 15, 2026 11:53 UTC